Table 1.
Basic characteristics of patients stratified in the DII quartile.
| Variable | DII | p-Value | |||
|---|---|---|---|---|---|
| Quartile 1 (n = 35) | Quartile 2 (n = 35) | Quartile 3 (n = 35) | Quartile 4 (n = 35) | ||
| (−3.24, −1.05) | (−1.05, 1.13) | (1.13, 2.67) | (2.67, 4.89) | ||
| Age (years) | 32.37 ± 2.75 | 32.63 ± 4.05 | 31.43 ± 3.28 | 33.91 ± 3.93 | 0.792 |
| BMI (kg/m2) | 20.29 ± 1.10 | 21.13 ± 1.04 | 21.61 ± 1.11 | 19.76 ± 1.12 | 0.071 |
| Handgrip strength (kg) | 31.43 ± 3.13 | 30.78 ± 2.94 | 37.44 ± 3.20 | 30.91 ± 2.96 | 0.005 * |
| Disease duration (years) | 4.80 ± 15.4 | 5.17 ± 1.39 | 4.49 ± 1.56 | 7.83 ± 2.43 | 0.030 * |
| C-Reactive Protein(mg/L) | 3.43 ± 7.68 | 8.23 ± 15.25 | 9.53 ± 18.79 | 15.55 ± 25.36 | 0.048 * |
| Hemoglobin(mg/L) | 133.83 ± 6.64 | 130.26 ± 9.18 | 133.46 ± 7.95 | 121.91 ± 6.58 | 0.096 |
| Albumin (mg/L) | 42.92 ± 1.54 | 41.80 ± 2.25 | 41.15 ± 1.83 | 41.36 ± 1.95 | 0.530 |
| ASMI (kg/m2) | 7.52 ± 0.39 | 7.33 ± 0.30 | 7.50 ± 0.41 | 6.84 ± 0.38 | 0.034 * |
| PG-SGA | 2.66 ± 0.84 | 4.32 ± 1.04 | 3.46 ± 0.90 | 5.86 ± 1.80 | 0.002 * |
| DII | −2.09 ± 0.23 | 0.06 ± 0.21 | 1.88 ± 0.16 | 3.39 ± 0.18 | <0.001 * |
| Male (%) | 82.86% | 68.57% | 71.43% | 65.71% | 0.406 |
| Smoking status | |||||
| Current smoker (%) | 2.86% | 2.86% | 2.86% | 8.57% | 0.710 |
| Former smoker (%) | 8.57% | 8.57% | 8.57% | 8.57% | |
| Nonsmoker (%) | 85.71% | 88.57% | 85.71% | 82.86% | |
| Drinker (%) | 2.86% | 0 | 2.86% | 2.86% | 0.801 |
| Montreal Classification-Location (%) | |||||
| L1 | 31.14% | 51.43% | 51.43% | 31.43% | 0.294 |
| L2 | 17.14% | 22.86% | 14.29% | 34.28% | |
| L3 | 42.86% | 25.71% | 34.29% | 34.28% | |
| L4 | 2.86% | 0 | 0 | 0 | |
| Montreal Classification-Behavior (%) | |||||
| B1 | 60.00% | 74.29% | 62.86% | 68.57% | 0.905 |
| B2 | 34.29% | 22.86% | 31.43% | 28.57% | |
| B3 | 5.71% | 2.86% | 5.71% | 2.86% | |
| Sarcopenia % | 20.00% | 20.00% | 8.57% | 57.14% | <0.001 * |
| Malnutrition % | 22.86% | 51.43% | 42.86% | 62.86% | 0.006 * |
| CDAI score | 82.30 ± 62.26 | 57.66 ± 73.60 | 67.54 ± 76.99 | 95.82 ± 67.49 | 0.394 |
| Active phase (%) | 17.14% | 17.14% | 11.42% | 14.28% | 0.893 |
* p < 0.05, using χ2 test for variables of proportion and one-way ANOVA for continuous variables. ASMI, appendicular skeletal muscle mass index. PG-SGA, Patient-Generated Subjective Global Assessment. Montreal Classification-Location, L1: terminal ileum, L2: colon, L3: ileocolon, and L4: involving the upper gastrointestinal tract. Montreal Classification-Behavior, B1: non-stricturing and non-penetrating, B2: stricturing, and B3: penetrating. CDAI, Crohn’s disease activity index, Active phase defined as CDAI ≥ 150.